Is elective cancer surgery feasible during the lock‐down period of the COVID‐19 pandemic? Analysis of a single institutional experience of 404 consecutive patients

Kulle, Cemil Burak; Azamat, İbrahim Fethi; Vatansever, Doğan; Erus, Suat; Tarim, Kayhan; Akyoldaş, Göktuğ; Gökler, Ozan; Deveci, Mehmet; Çakar, Nahit; Ergönül, Önder; Ağcaoğlu, Orhan; Kiremit, Murat Can; Yavuz, Ömer; Kırış, Talat; Ünsaler, Selin; Giray, Burak; Korkmaz, Murat; Dilege, Ece; Kılıç, Mert; Cesur, Ezgi; Solaroğlu, İhsan; Altuntaş, Ozan Muzaffer; Şimşek, Ayşe; Tanju, Serhan; Erkan, Mert; Canda, Erdem; Sasani, Mehdi; Hafiz, Ayşenur Meriç; Kordan, Yakup; Balık, Emre; Bilge, Orhan; Buğra, Dursun; Taşkiran, Ç.; Dilege, Şükrü

doi:10.1002/jso.26436

Cited by 8 publications

(7 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies in this area show that at the beginning of the pandemic process, elective health services almost came to a standstill; however, with the gains made in the fight against the pandemic over time, elective procedures are increasingly being performed. As the level of knowledge against COVID-19 contamination increases during the pandemic process, more active performance is demonstrated with fewer units in the fight against the disease (Assadian et al 2021;Kulle et al 2021;Chen and Ray 2021;Mallah et al 2021;Kaye et al 2020). In this way, other elective health services are also provided (Abu-Rumman 2021;Abu-Rumman et al 2021;Matsuyama et al 2021).…”

Section: Introductionmentioning

confidence: 99%

RETRACTED ARTICLE: Change in hospital admissions in dental diseases before and during the COVID-19 pandemic

Beleva

2022

Appl Nanosci

View full text Add to dashboard Cite

In this retrospective cross-sectional study, it was aimed to evaluate the negative effects of the pandemic process in the field of oral health by revealing the characteristics of applications made to a hospital related to oral health before and during the pandemic. Patient records who applied to Cyprus Science University Dentistry Hospital between October 2019 and March 2021 were included in the study. Gender, age, applied unit, applying frequency and procedure records were evaluated. Ethical approval was taken from Cyprus Science University. Patient records were divided into two groups as before pandemic ( n = 338) and during pandemic ( n = 1517). Results of the study showed that gender, age and applied unit distributions were not significantly different between before and during pandemic ( p > 0.05). Female and prosthesis applied patients were more common before and after COVID-19 pandemic. Detertrage, tooth extraction, night plaque, temporary cron, metal supported porcelain crown on implant, compomer filler and orthodontic diagnosis rates were decreased during pandemic, compared to before pandemic. Panaromic X-ray was the most common process before and during the pandemic. The differences between before and during pandemic were statistically significant ( p < 0.05). The results of the research show that the pandemic process in terms of oral health caused significant differences in the reasons for application, even in the population aged 34–36, the majority of whom are women.

show abstract

Section: Introductionmentioning

confidence: 99%

RETRACTED ARTICLE: Change in hospital admissions in dental diseases before and during the COVID-19 pandemic

Beleva

2022

Appl Nanosci

View full text Add to dashboard Cite

show abstract

“…These discrepancies may be due to the difference in how the pandemic affected the different study sites and the pandemic pattern during the study periods. 22 , 24 – 28 Brazil and the city of Sao Paulo have been heavily affected by the pandemic, and this study was conducted at a time when the country and city were massively affected—the so-called “first wave.”…”

Section: Discussionmentioning

confidence: 99%

Oncological Surgery During the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection

et al. 2022

View full text Add to dashboard Cite

Background Routine preoperative screening of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with reverse transcriptase-polymerase chain reaction (RT-PCR) may reduce in-hospital SARS-CoV-2 transmission. Methods This was a prospective, observational, cohort study. The endpoints were the incidence of asymptomatic patients with positive preoperative RT-PCR results and the incidence and factors associated with postoperative SARS-CoV-2 infection in patients with cancer referred for elective surgery. Patients with elective surgery between May and October 2020 were included. RT-PCR of nasopharyngeal swabs was performed preoperatively for all patients. Postoperative SARS-CoV-2 infection was assessed within 30 postoperative days. Results A total of 1636 preoperative screening RT-PCR tests were performed. Of these, 102 (6.2%) cases were positive, and 1,298 surgical procedures were analyzed. The postoperative SARS-CoV-2 infection rate was 0.9%. The length of stay (odds ratio [OR] 1.08; 95% confidence interval [CI] 1.04–1.11; p < 0.001), surgical time (OR 1.004; 95% CI 1.001–1.008; p = 0.023), intensive care unit admission (OR 7.7; 95% CI 2.03–29.28; p = 0.003), and hospital readmissions (OR 9.56; 95% CI 2.50–36.56; p = 0.001) were associated with postoperative coronavirus disease (COVID-19). Using unadjusted and adjusted logistic regression, length of stay (OR 1.08; 95% CI 1.04–1.11; p < 0.001), and readmission (OR 9.02; 95% CI 2.30–35.48; p = 0.002) were independent factors of postoperative COVID-19. Conclusions Screening patients preoperatively may reduce in-hospital SARS-CoV-2 transmission. Length of stay and readmission were independently correlated with postoperative COVID-19.

show abstract

“…Lastly, 20 studies provided data on overall Covid-19 infectivity (99601 gynecologic cancer, 8311468 overall control population). 15,17,23,29,31,[33][34][35]39,43,44,46,49,51,54,55,58,60 Covid-19 infection was comparable between gynecologic cancer and control (OR 0.97, CI 0.81-1.15, p 0.69, I 2 47%) Fig. S6.…”

Section: Overall Covid-19 Eventsmentioning

confidence: 93%

The Outcome of Gynecologic Cancer Patients With Covid-19 Infection: A Systematic Review And Meta-Analysis

Winata

Simatupang

Polim

et al. 2022

Preprint

View full text Add to dashboard Cite

ObjectiveCancer is comorbidity, which can lead to progressive worsening of Covid-19 with increased mortality. This is a systematic review and meta-analysis to get evidence of adverse outcomes of Covid-19 in gynecologic cancer.MethodsSearches through PubMed, Google Scholar, ScienceDirect, and medRxiv to find articles on the outcome of gynecologic cancer with Covid-19 (24 July 2021-19 February 2022). Newcastle-Ottawa Scale tool used to evaluate the quality of included studies. Pooled odds ratio (OR), 95% confidence interval (CI), random-effects model were presented. This study was registered to PROSPERO (CRD42021256557).ResultsWe accepted 49 studies with (1994 gynecologic cancer with Covid-19). Covid-19 infection was lower in gynecologic cancer vs hematologic cancer (OR 0.71, CI 0.56-0.89, p 0.003). Severe Covid and death were lower in gynecologic cancer vs lung and hematologic cancer (OR 0.36, CI 0.16-0.80, p 0.01), (OR 0.26, CI 0.10-0.67 p 0.005), (OR 0.52, CI 0.43-0.63, p <0.0001), (OR 0.65, CI 0.49-0.87, p 0.003) respectively. Increased Covid death is seen in gynecologic cancer vs breast, non-covid cancer, and non-cancer covid (OR 1.51, CI 1.20-1.90, p 0.0004), (OR 12.21, CI 8.39-17.77, p <0.0001), (OR 3.06, CI 2.32-4.04, p <0.0001) respectively.ConclusionGynecologic cancer had increased Covid-19 adverse outcomes compared to non-cancer, breast cancer, non-metastatic, and Covid-19 negative population. Gynecologic cancer had lowered Covid-19 adverse outcomes compared to other cancer types, lung cancer, and hematologic cancer. Lack of age and comorbidities stratification due to limited data were limitations. These findings may aid health policies and services during the ongoing global pandemic.SynopsisThis is a systematic review and meta analysis study that presents pooled evidence of outcome among gynecologic cancer patients infected with the Covid-19 infection. We manage to gather 49 studies involving 1994 gynecologic cancer patients with Covid-19, 220967 non cancer patients with Covid-19, 4080990 cancer patients without Covid-19 and 28658 non gynecologic cancer patients with Covid-19 for analysis. Meta analysis shows reduction of Covid-19 death with gynecologic cancer patients vs overall other cancer, lung cancer, and hematologic cancer (OR 0.84, CI 0.72-0.97, p 0.02), (OR 0.52, CI 0.43-0.63, p <0.0001), (OR 0.65, CI 0.49-0.87, p 0.003) respectively. On the contrary, increased risk of Covid-19 death occur to gynecologic cancer patients vs infected non cancer, non Covid cancer patients, and infected breast cancer patients (OR 3.06, CI 2.32-4.04, p <0.0001), (OR 12.21, CI 8.39-17.77, p <0.0001), (OR 1.51, CI 1.20-1.90, p 0.0004) respectively. Analysis from SARS-Cov-2 infection shows lower infection with gynecologic cancer patients vs hematologic cancer cohort (OR 0.71, CI 0.56-0.89, p 0.003). We hope the result of this meta analysis will be useful to providers practicing in cancer centers and tertiary cancer referral hospitals thus better practices and care services given to gynecologic cancer patients infected with / without the Covid-19 during the ongoing global pandemic can be achieved.To our knowledge this is the first systematic review and meta analysis which emphasizes on reporting the outcome of gynecologic cancer patients with the Covid-19 infection. We also found no publication bias across 49 studies we have gathered and used as meta analysis data.

show abstract

Is elective cancer surgery feasible during the lock‐down period of the COVID‐19 pandemic? Analysis of a single institutional experience of 404 consecutive patients

Cited by 8 publications

References 19 publications

RETRACTED ARTICLE: Change in hospital admissions in dental diseases before and during the COVID-19 pandemic

RETRACTED ARTICLE: Change in hospital admissions in dental diseases before and during the COVID-19 pandemic

Oncological Surgery During the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection

The Outcome of Gynecologic Cancer Patients With Covid-19 Infection: A Systematic Review And Meta-Analysis

Contact Info

Product

Resources

About